News
Sign up for updates
Contact Us
Trials
If you are interested in participating or learning about future trials, then please complete the form on our contact page or contact the team at trials@exsurgo.com.
For sales enquiries and trials outside Auckland
For all other trials and sales enquiries please contact the team at enquiries@exsurgo.com.
Media
For all media enquires please contact the team at pr@exsurgo.com with your contact details and request. Images and video of the Axon product are available upon request.
Filter
East Kent chronic pain management medical trial launches in the UK
Exsurgo has launched new study using EEG neurofeedback as a therapy to manage neuropathic pain in the United Kingdom. Funded by Exsurgo, the new trial is being led by researchers from the East Kent…
READDecember 16, 2022
When a game is more than play
Whether it’s smoking, drinking, eating unhealthy food or even mindlessly scrolling through social media, people can’t resist a quick hit of pleasure despite knowing the long-term pitfalls of such …
READNovember 30, 2022
Exsurgo’s Mindpower Newsletter – November 2022
Hi all, We are thrilled to share that our final trialist has completed the Active Neurofeedback Treatment phase of the New Zealand Axon trial in partnership with Auckland University of Technology (AUT…
READExsurgo’s Mindpower Newsletter – August 2022
Hi all Medication, physical therapy and surgery are common treatments for pain – but this is by no means an exhaustive list. Last week, we asked those following our social media for their go-to…
READAugust 17, 2022
Clinical trials in a pandemic: why the show must go on
In medicine, triage is a term used to explain how treatment is prioritised for those most in need of care. It’s often used to talk about emergencies or acute injuries, where there may be a shor…
READAugust 8, 2022
Exsurgo’s Mindpower Newsletter – July 2022
Hi all, It’s hard to believe it’s been over a year since we announced the results from our UK proof-of-concept trial, demonstrating the exciting potential of our Axon system to treat chro…
READJuly 6, 2022
